Physician profile
Sangeetha Setty
NPI 1063822385
$15,240.07
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2021: $99.90 · 2022: $96.28 · 2023: $11K · 2024: $3,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,500 · Travel and Lodging: $4,584 · Food and Beverage: $1,609 · Education: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,500.00 |
| Travel and Lodging | $4,583.90 |
| Food and Beverage | $1,608.67 |
| Education | $1,134.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,446.08 | 2023-2024 | Synchromedii, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $1,947.93 | 2023-2024 | Senza, Nevro |
| Abbott Laboratories | $1,344.52 | 2023-2024 | Proclaim, Eterna |
| Curonix LLC | $973.41 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Fresenius Kabi USA, LLC | $99.90 | 2021 | |
| Spr Therapeutics, INC | $81.97 | 2024 | Sprint Pns System |
| Heron Therapeutics, INC. | $80.52 | 2022 | |
| Horizon Therapeutics Plc | $74.75 | 2019 | |
| Averitas Pharma INC. | $18.88 | 2024 | Qutenza |
| Novo Nordisk INC | $16.77 | 2019 | |
| Merck Sharp & Dohme LLC | $15.76 | 2022 | |
| Ibsa Pharma INC. | $14.58 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sangeetha Setty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.